Hyloris Partner AFT Signs Exclusive Japan Deal For Maxigesic IV
(RTTNews) - Hyloris Pharmaceuticals SA (HYL.BR) announced that its partner AFT Pharmaceuticals Ltd. (AFT.NZ) has entered into an exclusive agreement with Mikasa Seiyaku Co Ltd. for the commercialization of Maxigesic IV in Japan.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.